Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Ludwig Announces Engagement of Marvin S. Hausman MD as Chief Science Consultant

The Addition of the Prestigious Dr. Hausman Sets Up the Latest Technology Venture with High Credibility and Solid Medical Backing

SPARKS, NV / ACCESSWIRE / July 19, 2022 / (OTC PINK:LUDG) This news comes in a series of recent announcements of successful new funding rounds and new directional changes within the company. Adding Dr. Hausman is the next step in the company's evolution to pave the way for a highly credible, leading-edge medical technology. That's due to the extensive and highly reputable career of Dr. Hausman.

As Chairman of the Scientific Advisory Board, Dr. Hausman is an Immunologist and Board-Certified Urological Surgeon with more than 40 years of drug research and development experience with various pharmaceutical companies, including Bristol-Myers International, Mead-Johnson Pharmaceutical Co., E.R. Squibb, Medco Research, and Axonyx.

He was a co-founder of Medco Research Inc., an NYSE-listed clinical research organization and biotechnology company specializing in adenosine products that King Pharmaceuticals subsequently acquired. Dr. Hausman was also a co-founder of Axonyx and served in various capacities as President, CEO, and Chairman until the company merged into NASDAQ-listed Torrey Pines Therapeutics Inc. in 2006. Dr. Hausman is currently Chairman of the Board of Directors and Chief Science and Technology Officer of Entia Biosciences Inc.

Additionally, Dr. Hausman has residencies in General Surgery at Mt. Sinai Hospital in New York and Urological Surgery at UCLA Medical Center. He received his medical degree from the New York University School of Medicine and is on the Alumni Board of Governors of NYU Grossman School of Medicine.

Dr. Hausman, "It is with great pleasure that I will get the opportunity to guide Ludwig with my extensive career and medical background, particularly in the latest direction of breakthrough medical technology the company has taken."

Anne Blackstone, CEO of Ludwig, replied, "Having Dr. Hausman as Chief Science Consultant" is essential in establishing our credibility and strong science background in our new scientific medical technologies. We are very fortunate to have him."

About Ludwig: Ludwig Enterprises, Inc. is an innovative technology and health-related company. Ludwig is endeavoring to return to and expand healthy living and other health technology products. The Board of Directors believes this course change returning to our core focus will be in Ludwig shareholders' best interest.

SAFE HARBOR

Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements are not a guarantee of future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately priced, retain, and complete projects and changes in products and competition.

CONTACT:

Ludwig Enterprises,

Anne Blackstone,

786-235-9026

or

HQ@ludwigent.com

SOURCE: Ludwig Enterprises, Inc.



View source version on accesswire.com:
https://www.accesswire.com/709011/Ludwig-Announces-Engagement-of-Marvin-S-Hausman-MD-as-Chief-Science-Consultant

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.